Skip to main content
NewslettersWatchlist

Twist Bioscience Corp(TWST-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low42.71
Day High47.47
Open:42.71
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Why Shares of Twist Bioscience Are Up Friday
Motley Fool
2 Cathie Wood Growth Stocks That Could Make You Richer
Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
Motley Fool
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
Business Wire
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Motley Fool
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
Business Wire
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
Business Wire
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
Business Wire
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
Business Wire
DNA Data Storage Alliance Announces Board Appointments
Business Wire
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Business Wire
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
Business Wire
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
Business Wire
TWST FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
Business Wire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate
PR Newswire
TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
PR Newswire
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
Twist Bioscience Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Twist Bioscience Corporation of Deadline in Securities Fraud Class Action Lawsuit
PR Newswire
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
PR Newswire
TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Twist Bioscience Corporation (NASDAQ: TWST)
Business Wire
TWIST BIOSCIENCE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
Motley Fool
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
Business Wire
Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT
PR Newswire
TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST
PR Newswire
TWST FINAL DEADLINE FRIDAY: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST
PR Newswire
TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
PR Newswire
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST
Motley Fool
Why Twist Bioscience Stock Is Sinking Today
Business Wire
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results

Profile

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.